However, given that the available healthcare budget is limited, two questions apply:
- How will government, as well as the private sector, determine what is covered under their benefits packages?; and
- What informs the choice of a new drug, device or intervention?
Commenting on the introduction of the NHI, Professor Andrew Briggs – a world expert on health technology assessment (HTA) at the University of Glasgow, Scotland – said that “process and governance issues will need to be clarified and followed in full” before the government could decide on a universally beneficial and equitable basket of healthcare services…..more